Talentum BioTech is a division of Artificial Intelligence Talentum, which originated from the collaboration between the company and the Bioinformatics and High Performance Computing (Bio-HPC) Research Group at the Universidad Católica San Antonio de Murcia (UCAM).
The objective of this project is the transference to the company and subsequent commercial exploitation of the in silico bioactive compund discovery technology devised by UCAM’s research group.
The project’s initial definition started in the late 2014, and by the end of this same year, a proposal is presented to the technology transfer project “TETRACOM”, sponsored by the FP7 programme of the European Commision. This proposal was accepted in february 2015, which meant the final push for the project, starting in May 2015.
Amparo Roca Sabater
Project Manager & Coordinator
Amparo holds a BSc in Economics from the University of Murcia (Spain). She has additional training in International Trading and is preparing her Ph.D. in Social Sciences at the Catholic University of Murcia (Spain). She joined Artificial Intelligence Talentum in 2013 and became a fundamental cohesive element by coordinating the different departments in the company.
Antonio Vicente Contreras
Chief Executive Officer (CEO)
Antonio obtained his Master Diploma of Advanced Studies in Computer and Languages Systems in the University of Murcia (Spain). Currently he is working in a Ph.D. in Computing Science at the Catholic University of Murcia (Spain).
He has developed his career as a professional of strategic and operational consulting in the areas of Software and Services. His experience in managing software companies as well as in sales department is more than proven with over 10 years of interational activity. Besides being founder and CEO of Artificial Intelligence Talentum, he acts as Head of Sales at Taletum Biotech, contributing to both projects with his expertise in business development.
Horacio Pérez Sánchez
Leader of the BIO-HPC Research Group (UCAM)
Dr. Horacio Pérez Sánchez obtained his Ph.D. degree in Theoretical and Computational Chemistry from the University of Murcia (Spain) in 2006. He performed research in several European Institutions such as the Institute of Structural Biology (CEA, Grenoble, France) and at the Karlsruhe Institute of Technology (Karlsruhe, Germany), where he developed new methodologies for drug discovery and implemented them in parallel architectures. Currently he is full-time researcher and Principal Investigator of the “Bioinformatics and High Performance Computing” research group at the Catholic University of Murcia (Spain).
Was this information useful?x